Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, fondata nel 1982. In collaborazione con l'Associazione Culturale Pediatri.
Login Abbonamenti Pubblicazioni Carrello Registrazione Perché registrarsi? Contatti

Il punto su

PDF

La gestione del bambino con ipercolesterolemia familiare

Management of familial hypercholesterolaemia in children

Gennaro Giovanni Viviano
Già Responsabile Emergenza Pediatrica DEA Ospedale Bambino Gesù Roma

Febbraio 2014

Abstract
Among hypercholesterolaemias, familial hypercholesterolaemia is a hereditary dyslipidaemia characterised by an isolated and permanent increase in circulating low-density lipoprotein (LDL) levels. The heterozygous form is often clinically silent and may be diagnosed at any age following a lipid analysis and a familial history of coronary artery disease, a personal history of coronary artery disease and extravascular deposits, and an isolated hypercholesterolaemia that does not respond to a lipid-controlled diet. The homozygous form is the most serious, and luckily it is rare, with onset in the first two years of life; it is characterised by cutaneous or tendon xanthomas, high LDL levels, and an arteriopathy that manifests within 10 years of age. An early diagnosis can improve clinical evolution, so an early and specific approach to children who present with the disease or have a familial history of dyslipidaemia is necessary.
Contenuto riservato

Per leggere l'articolo è necessario effettuare il login.

Bibliografia
Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become obese adults? A review of the literature. Prev Med 1993;22:167-77. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6. Daniels SR, Pratt CA, Hayman LL. Reduction of risk for cardiovascular disease in children and adolescents. Circulation 2011;124:1673-86. Freedman DS, Srinivasan SR, Cresanta JL, Webber LS, Berenson GS. Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Serum lipids and lipoproteins. Pediatrics 1987;80:789-96. Napoli C, Glass CK, Witztum JL, Deutsch R, D'Armiento FP, Palinski W. Influence of Maternal Hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet 1999;354:1234-41. Owen CG, Whincup PH, Odoki K, Gilg JA, Cook DG. Infant feeding and blood cholesterol: study in adolescents and a systematic review. Pediatrics 2002;110,3:597-608. Tonstad S, Aksnes L. Fat soluble vitamin levels in familial hypercholesterolemia. J Pediatrics 1997;130:274-80. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th Edn. New York: McGraw‐Hill 2001;2863–913. Durrington P. Dyslipidaemia. Lancet 2003;362:717-71. Canniotto Z. Statine, iperlipemia e obesità. Stato dell’arte. Medico e Bambino. 2008;27:309-31. Bartolozzi G. Lo screening dei lipidi e delle lipoproteine in pediatria (parte prima). Medico e Bambino 2008 (pagine elettroniche);11(7). Buser F, Riesen WF, Mordasini R. Lipid screening in paediatrics for early detection of cardiovascular risks. J Clin Chem Clin Biochem 1990;28:107-11.